Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clifford Bryant

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Plos Computational Biology|July 7, 2011
Predicting binding to p-glycoprotein by flexible receptor dockingElena Dolghih, Clifford Bryant, Adam R Renslo, et al.
Nature|July 11, 2017
K<sub>2P</sub>2.1 (TREK-1)-activator complexes reveal a cryptic selectivity filter binding siteMarco Lolicato, Cristina Arrigoni, Takahiro Mori, et al.
ACS Chemical Neuroscience|August 10, 2018
Protein and Chemical Determinants of BL-1249 Action and Selectivity for K<sub>2P</sub> ChannelsLianne Pope, Cristina Arrigoni, Hubing Lou, et al.
Journal of Medicinal Chemistry|July 30, 2009
Divergent modes of enzyme inhibition in a homologous structure-activity seriesRafaela S Ferreira, Clifford Bryant, Kenny K H Ang, et al.
Bioorganic & Medicinal Chemistry|August 2, 2002
Peptidic 1-cyanopyrrolidines: synthesis and SAR of a series of potent, selective cathepsin inhibitorsRobert M Rydzewski, Clifford Bryant, Renata Oballa, et al.
Bioorganic & Medicinal Chemistry Letters|July 7, 2015
Tetrafluorophenoxymethyl ketone cruzain inhibitors with improved pharmacokinetic properties as therapeutic leads for Chagas' diseaseR Jeffrey Neitz, Clifford Bryant, Steven Chen, et al.
Antimicrobial Agents and Chemotherapy|May 14, 2014
Hsp90 inhibitors as new leads to target parasitic diarrheal diseasesAnjan Debnath, Dea Shahinas, Clifford Bryant, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Development of covalent chemogenetic K<sub>2P</sub> channel activatorsParker E Deal, Haerim Lee, Abhisek Mondal, et al.
Chemmedchem|March 20, 2013
2-Aminothiazoles with improved pharmacotherapeutic properties for treatment of prion diseaseZhe Li, B Michael Silber, Satish Rao, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 2011
SAR studies on dihydropyrimidinone antibioticsLianhong Xu, Lijun Zhang, Robert Jones, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Plos Computational Biology|July 7, 2011
Predicting binding to p-glycoprotein by flexible receptor dockingElena Dolghih, Clifford Bryant, Adam R Renslo, et al.
Nature|July 11, 2017
K<sub>2P</sub>2.1 (TREK-1)-activator complexes reveal a cryptic selectivity filter binding siteMarco Lolicato, Cristina Arrigoni, Takahiro Mori, et al.
ACS Chemical Neuroscience|August 10, 2018
Protein and Chemical Determinants of BL-1249 Action and Selectivity for K<sub>2P</sub> ChannelsLianne Pope, Cristina Arrigoni, Hubing Lou, et al.
Journal of Medicinal Chemistry|July 30, 2009
Divergent modes of enzyme inhibition in a homologous structure-activity seriesRafaela S Ferreira, Clifford Bryant, Kenny K H Ang, et al.
Bioorganic & Medicinal Chemistry|August 2, 2002
Peptidic 1-cyanopyrrolidines: synthesis and SAR of a series of potent, selective cathepsin inhibitorsRobert M Rydzewski, Clifford Bryant, Renata Oballa, et al.
Bioorganic & Medicinal Chemistry Letters|July 7, 2015
Tetrafluorophenoxymethyl ketone cruzain inhibitors with improved pharmacokinetic properties as therapeutic leads for Chagas' diseaseR Jeffrey Neitz, Clifford Bryant, Steven Chen, et al.
Antimicrobial Agents and Chemotherapy|May 14, 2014
Hsp90 inhibitors as new leads to target parasitic diarrheal diseasesAnjan Debnath, Dea Shahinas, Clifford Bryant, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Development of covalent chemogenetic K<sub>2P</sub> channel activatorsParker E Deal, Haerim Lee, Abhisek Mondal, et al.
Chemmedchem|March 20, 2013
2-Aminothiazoles with improved pharmacotherapeutic properties for treatment of prion diseaseZhe Li, B Michael Silber, Satish Rao, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 2011
SAR studies on dihydropyrimidinone antibioticsLianhong Xu, Lijun Zhang, Robert Jones, et al.
Pageof 2